20 October, 2024 in Videos No More Side Effects: Nexalin’s Non-Invasive Approach to Treating Depression & PTSD
29 July, 2024 in Investor Relations, Videos Discover Nexalin’s Neurostimulation Device Targeting Mental Health Disorders
18 April, 2024 in Investor Relations, Videos Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device
